Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Acaba

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Boletin De La Asociacion Medica De Puerto Rico|May 13, 1998
Adult bone marrow transplantation in Puerto Rico: past, present, and futureL Acaba
Cancer Investigation|January 1, 1993
Improving the role of hematopoietic support for high-dose cytotoxic therapyS C Gulati, L Acaba
Journal of Hematotherapy|January 1, 1993
Rationale for purging in autologous stem cell transplantationS C Gulati, L Acaba
Cancer Investigation|January 1, 1995
Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignanciesC Wasserheit, L Acaba, S Gulati
Boletin De La Asociacion Medica De Puerto Rico|January 6, 2001
Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levelsL Acaba, A Mangual, E Vélez García
Leukemia|November 1, 1992
Acute lymphoblastic leukemia: present and futureS C Gulati, L Acaba, P Maslak, et al.
Boletin De La Asociacion Medica De Puerto Rico|June 10, 2000
Simultaneous occurrence of Hodgkin's disease and chronic lymphocyte leukemia: a unique presentationL Acaba, D Hallman, E Rodríguez-Morales, et al.
Current Opinion in Oncology|April 1, 1992
Purging in autologous and allogeneic bone marrow transplantationS C Gulati, R M Lemoli, L Acaba, et al.
Bone Marrow Transplantation|August 1, 1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrowS Gulati, L Acaba, J Yahalom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantationS Gulati, J Yahalom, L Acaba, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Boletin De La Asociacion Medica De Puerto Rico|May 13, 1998
Adult bone marrow transplantation in Puerto Rico: past, present, and futureL Acaba
Cancer Investigation|January 1, 1993
Improving the role of hematopoietic support for high-dose cytotoxic therapyS C Gulati, L Acaba
Journal of Hematotherapy|January 1, 1993
Rationale for purging in autologous stem cell transplantationS C Gulati, L Acaba
Cancer Investigation|January 1, 1995
Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignanciesC Wasserheit, L Acaba, S Gulati
Boletin De La Asociacion Medica De Puerto Rico|January 6, 2001
Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levelsL Acaba, A Mangual, E Vélez García
Leukemia|November 1, 1992
Acute lymphoblastic leukemia: present and futureS C Gulati, L Acaba, P Maslak, et al.
Boletin De La Asociacion Medica De Puerto Rico|June 10, 2000
Simultaneous occurrence of Hodgkin's disease and chronic lymphocyte leukemia: a unique presentationL Acaba, D Hallman, E Rodríguez-Morales, et al.
Current Opinion in Oncology|April 1, 1992
Purging in autologous and allogeneic bone marrow transplantationS C Gulati, R M Lemoli, L Acaba, et al.
Bone Marrow Transplantation|August 1, 1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrowS Gulati, L Acaba, J Yahalom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantationS Gulati, J Yahalom, L Acaba, et al.
Pageof 2